Cargando…

Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study

OBJECTIVE: We aimed to determine the corneal confocal microscopy (CCM) parameter that best identifies diabetic sensorimotor polyneuropathy (DSP) in type 1 diabetes and to describe its performance characteristics. RESEARCH DESIGN AND METHODS: Concurrent with clinical and electrophysiological examinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ausma, Bril, Vera, Orszag, Andrej, Paulson, Jenna, Yeung, Emily, Ngo, Mylan, Orlov, Steven, Perkins, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308301/
https://www.ncbi.nlm.nih.gov/pubmed/22323412
http://dx.doi.org/10.2337/dc11-1396
_version_ 1782227420523266048
author Ahmed, Ausma
Bril, Vera
Orszag, Andrej
Paulson, Jenna
Yeung, Emily
Ngo, Mylan
Orlov, Steven
Perkins, Bruce A.
author_facet Ahmed, Ausma
Bril, Vera
Orszag, Andrej
Paulson, Jenna
Yeung, Emily
Ngo, Mylan
Orlov, Steven
Perkins, Bruce A.
author_sort Ahmed, Ausma
collection PubMed
description OBJECTIVE: We aimed to determine the corneal confocal microscopy (CCM) parameter that best identifies diabetic sensorimotor polyneuropathy (DSP) in type 1 diabetes and to describe its performance characteristics. RESEARCH DESIGN AND METHODS: Concurrent with clinical and electrophysiological examination for classification of DSP, CCM was performed on 89 type 1 diabetic and 64 healthy subjects to determine corneal nerve fiber length (CNFL), density, tortuosity, and branch density. Area under the curve (AUC) and optimal thresholds for DSP identification in those with diabetes were determined by receiver operating characteristic (ROC) curve analysis. RESULTS: DSP was present in 33 (37%) subjects. With the exception of tortuosity, CCM parameters were significantly lower in DSP case subjects. In ROC curve analysis, AUC was greatest for CNFL (0.88) compared with fiber density (0.84, P = 0.0001), branch density (0.73, P < 0.0001), and tortuosity (0.55, P < 0.0001). The threshold value that optimized sensitivity and specificity for ruling in DSP was a CNFL of ≤14.0 mm/mm(2) (sensitivity 85%, specificity 84%), associated with positive and negative likelihood ratios of 5.3 and 0.18. An alternate approach that used separate threshold values maximized sensitivity (threshold value ≥15.8 mm/mm(2), sensitivity 91%, negative likelihood ratio 0.16) and specificity (≤11.5 mm/mm(2), specificity 93%, positive likelihood ratio 8.5). CONCLUSIONS: Among CCM parameters, CNFL best discriminated DSP cases from control subjects. A single threshold offers clinically acceptable operating characteristics, although a strategy that uses separate thresholds to respectively rule in and rule out DSP has excellent performance while minimizing unclassified subjects. We hypothesize that values between these thresholds indicate incipient nerve injury that represents those individuals at future neuropathy risk.
format Online
Article
Text
id pubmed-3308301
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-33083012013-04-01 Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study Ahmed, Ausma Bril, Vera Orszag, Andrej Paulson, Jenna Yeung, Emily Ngo, Mylan Orlov, Steven Perkins, Bruce A. Diabetes Care Original Research OBJECTIVE: We aimed to determine the corneal confocal microscopy (CCM) parameter that best identifies diabetic sensorimotor polyneuropathy (DSP) in type 1 diabetes and to describe its performance characteristics. RESEARCH DESIGN AND METHODS: Concurrent with clinical and electrophysiological examination for classification of DSP, CCM was performed on 89 type 1 diabetic and 64 healthy subjects to determine corneal nerve fiber length (CNFL), density, tortuosity, and branch density. Area under the curve (AUC) and optimal thresholds for DSP identification in those with diabetes were determined by receiver operating characteristic (ROC) curve analysis. RESULTS: DSP was present in 33 (37%) subjects. With the exception of tortuosity, CCM parameters were significantly lower in DSP case subjects. In ROC curve analysis, AUC was greatest for CNFL (0.88) compared with fiber density (0.84, P = 0.0001), branch density (0.73, P < 0.0001), and tortuosity (0.55, P < 0.0001). The threshold value that optimized sensitivity and specificity for ruling in DSP was a CNFL of ≤14.0 mm/mm(2) (sensitivity 85%, specificity 84%), associated with positive and negative likelihood ratios of 5.3 and 0.18. An alternate approach that used separate threshold values maximized sensitivity (threshold value ≥15.8 mm/mm(2), sensitivity 91%, negative likelihood ratio 0.16) and specificity (≤11.5 mm/mm(2), specificity 93%, positive likelihood ratio 8.5). CONCLUSIONS: Among CCM parameters, CNFL best discriminated DSP cases from control subjects. A single threshold offers clinically acceptable operating characteristics, although a strategy that uses separate thresholds to respectively rule in and rule out DSP has excellent performance while minimizing unclassified subjects. We hypothesize that values between these thresholds indicate incipient nerve injury that represents those individuals at future neuropathy risk. American Diabetes Association 2012-04 2012-03-13 /pmc/articles/PMC3308301/ /pubmed/22323412 http://dx.doi.org/10.2337/dc11-1396 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Ahmed, Ausma
Bril, Vera
Orszag, Andrej
Paulson, Jenna
Yeung, Emily
Ngo, Mylan
Orlov, Steven
Perkins, Bruce A.
Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study
title Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study
title_full Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study
title_fullStr Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study
title_full_unstemmed Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study
title_short Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study
title_sort detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308301/
https://www.ncbi.nlm.nih.gov/pubmed/22323412
http://dx.doi.org/10.2337/dc11-1396
work_keys_str_mv AT ahmedausma detectionofdiabeticsensorimotorpolyneuropathybycornealconfocalmicroscopyintype1diabetesaconcurrentvaliditystudy
AT brilvera detectionofdiabeticsensorimotorpolyneuropathybycornealconfocalmicroscopyintype1diabetesaconcurrentvaliditystudy
AT orszagandrej detectionofdiabeticsensorimotorpolyneuropathybycornealconfocalmicroscopyintype1diabetesaconcurrentvaliditystudy
AT paulsonjenna detectionofdiabeticsensorimotorpolyneuropathybycornealconfocalmicroscopyintype1diabetesaconcurrentvaliditystudy
AT yeungemily detectionofdiabeticsensorimotorpolyneuropathybycornealconfocalmicroscopyintype1diabetesaconcurrentvaliditystudy
AT ngomylan detectionofdiabeticsensorimotorpolyneuropathybycornealconfocalmicroscopyintype1diabetesaconcurrentvaliditystudy
AT orlovsteven detectionofdiabeticsensorimotorpolyneuropathybycornealconfocalmicroscopyintype1diabetesaconcurrentvaliditystudy
AT perkinsbrucea detectionofdiabeticsensorimotorpolyneuropathybycornealconfocalmicroscopyintype1diabetesaconcurrentvaliditystudy